AIRLINK 196.15 Increased By ▲ 4.31 (2.25%)
BOP 10.17 Increased By ▲ 0.30 (3.04%)
CNERGY 7.89 Increased By ▲ 0.22 (2.87%)
FCCL 38.47 Increased By ▲ 0.61 (1.61%)
FFL 16.08 Increased By ▲ 0.32 (2.03%)
FLYNG 25.48 Increased By ▲ 0.17 (0.67%)
HUBC 130.80 Increased By ▲ 0.63 (0.48%)
HUMNL 13.85 Increased By ▲ 0.26 (1.91%)
KEL 4.67 No Change ▼ 0.00 (0%)
KOSM 6.31 Increased By ▲ 0.10 (1.61%)
MLCF 45.34 Increased By ▲ 1.05 (2.37%)
OGDC 210.24 Increased By ▲ 3.37 (1.63%)
PACE 6.67 Increased By ▲ 0.11 (1.68%)
PAEL 41.25 Increased By ▲ 0.70 (1.73%)
PIAHCLA 17.79 Increased By ▲ 0.20 (1.14%)
PIBTL 8.15 Increased By ▲ 0.08 (0.99%)
POWER 9.36 Increased By ▲ 0.12 (1.3%)
PPL 181.20 Increased By ▲ 2.64 (1.48%)
PRL 39.91 Increased By ▲ 0.83 (2.12%)
PTC 24.60 Increased By ▲ 0.46 (1.91%)
SEARL 110.51 Increased By ▲ 2.66 (2.47%)
SILK 0.99 Increased By ▲ 0.02 (2.06%)
SSGC 38.55 Decreased By ▼ -0.56 (-1.43%)
SYM 19.30 Increased By ▲ 0.18 (0.94%)
TELE 8.85 Increased By ▲ 0.25 (2.91%)
TPLP 12.39 Increased By ▲ 0.02 (0.16%)
TRG 66.30 Increased By ▲ 0.29 (0.44%)
WAVESAPP 12.48 Decreased By ▼ -0.30 (-2.35%)
WTL 1.70 No Change ▼ 0.00 (0%)
YOUW 3.99 Increased By ▲ 0.04 (1.01%)
BR100 12,096 Increased By 166.1 (1.39%)
BR30 36,068 Increased By 408.8 (1.15%)
KSE100 114,997 Increased By 1790.4 (1.58%)
KSE30 36,153 Increased By 588.3 (1.65%)

A meeting of the Cancer Research Group, Pakistan was held at the office of Pakistan Society of Clinical Oncology (PSCO) here to discuss the rising cost of treatment of cancer in Pakistan.
The meeting urged the need to provide modern treatment on cost-effective basis, and disclosed that a research trial will be started here to establish the optimum dosage of drugs for Pakistani breast cancer patients.
Eminent oncologists of the country including Professor Abrar Javed, Major General Badshah Khan, Dr Ijaz Hussain Shah, Dr Ahmad Usman, Dr Sohail Murad, Dr Muneeb and others were present on the occasion, while Professor Dr Shaharyar acted as co-ordinator.
Recruitment of patients for this research study will start in mid March, and preliminary results will be available in late 2007. It is anticipated that successful completion of this trial will enable physicians to treat advanced breast cancer patients at half the existing cost, while using most modern drug therapy. The research group was established in 1999 with the objective to find solutions for the local cancer problems and to customise modern treatments according to local circumstances.

Copyright Associated Press of Pakistan, 2006

Comments

Comments are closed.